Studies have shown that nicotine activates the nAChR, which helps to protect against Aβ-induced toxicity, while scavenging the peptide—an effect that contributes to the treatment of AD, with a potential role for the nAChR as a therapeutic target [152]. Here, CHRNA4 is linked to Alzheimer disease.